Emerging trends in antibiotic resistance: Implications for emergency medicine

被引:37
作者
Pourmand, Ali [1 ,4 ]
Mazer-Amirshahi, Maryann [2 ,5 ]
Jasani, Gregory [1 ,4 ]
May, Larissa [3 ]
机构
[1] George Washington Univ, Dept Emergency Med, Washington, DC 20037 USA
[2] MedStar Washington Hosp Ctr, Dept Emergency Med, Washington, DC USA
[3] Univ Calif Davis, Dept Emergency Med, Davis, CA USA
[4] George Washington Univ, Sch Med & Hlth Sci, Washington, DC 20037 USA
[5] Georgetown Univ, Sch Med, Washington, DC USA
关键词
URINARY-TRACT-INFECTIONS; BLOOD-STREAM INFECTION; PSEUDOMONAS-AERUGINOSA; STAPHYLOCOCCUS-AUREUS; ANTIMICROBIAL STEWARDSHIP; NEISSERIA-GONORRHOEAE; KLEBSIELLA-PNEUMONIAE; ECONOMIC OUTCOMES; ESCHERICHIA-COLI; DOUBLE-BLIND;
D O I
10.1016/j.ajem.2017.03.010
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background: Many bacteria are demonstrating increasing levels of resistance to commonly used antibiotics. While this has implications for the healthcare system as a whole, many patients infected with these resistant organisms will initially present to the emergency department (ED). The purpose of this review is to provide a summary of current trends in infections caused by the most clinically relevant resistant organisms encountered in emergency medicine. Methods: Bacteria were selected based on the Centers for Disease Control and Prevention's National Action Plan for Combating Antibiotic Resistant Bacteria, and PubMed database. Results: The following bacteria were included: methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococci, Escherichia coli, carbapenem-resistant Enterobacteriaceae, Neisseria gonorrhoeae, and Pseudomonas aeruginosa. All have shown increasing rates of resistance to one or more of the antibiotics commonly used to treat them. Increasing rates of antibiotic resistance are associated with worse clinical outcomes and greater healthcare costs. Conclusions: Antibiotic resistance is increasing and poses significant a risk to both the patient and public health as a whole. Appropriate choice of initial antibiotic is important in improving clinical outcomes, which is often the role of the ED provider. On a broader level, the ED must also take part in institutional efforts such as Antibiotic Stewardship Programs, which have been shown to decrease costs and rates of infection with resistant organisms. Ultimately, a multifaceted approach will be required to curb the threat of antibiotic-resistant bacteria. (C) 2017 Elsevier Inc. All rights reserved.
引用
收藏
页码:1172 / 1176
页数:5
相关论文
共 63 条
[1]   Multidrug-resistant Pseudomonas aeruginosa: Risk factors and clinical impact [J].
Aloush, V ;
Navon-Venezia, S ;
Seigman-Igra, Y ;
Cabili, S ;
Carmeli, Y .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (01) :43-48
[2]  
American College of Emergency Physicians, 2013, AV ANT WOUND CULT EM
[3]  
[Anonymous], 2010, NAT HOSP AMB MED CAR
[4]  
[Anonymous], 2010, Sexually Transmitted Disease Surveillance 2009
[5]  
[Anonymous], 2016, FDA Drug Safety Communication: FDA strengthens warnings and changes prescribing instructions to decrease the risk of serious allergic reactions with anemia drug Feraheme
[6]  
[Anonymous], 2016, SEX TRANSM DIS SURV
[7]   The rise of the Enterococcus: beyond vancomycin resistance [J].
Arias, Cesar A. ;
Murray, Barbara E. .
NATURE REVIEWS MICROBIOLOGY, 2012, 10 (04) :266-278
[8]   Oral Treatment Options for Ambulatory Patients with Urinary Tract Infections Caused by Extended-Spectrum-β-Lactamase-Producing Escherichia coli [J].
Auer, Simon ;
Wojna, Alexandra ;
Hell, Markus .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (09) :4006-4008
[9]   Systematic Review and Meta-Analysis of Linezolid versus Daptomycin for Treatment of Vancomycin-Resistant Enterococcal Bacteremia [J].
Balli, Eleni P. ;
Venetis, Chris A. ;
Miyakis, Spiros .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (02) :734-739
[10]  
Barton Michelle, 2006, Can J Infect Dis Med Microbiol, V17 Suppl C, p4C